Encephalopathy in a patient with loiasis treated with albendazole: A case report

Whittaker, 2018, Loa loa: more than meets the eye?, Trends Parasitol., 34, 261, 10.1016/j.pt.2018.02.002 Chesnais, 2017, Excess mortality associated with loiasis: a retrospective population-based cohort study, Lancet Infect. Dis., 17, 108, 10.1016/S1473-3099(16)30405-4 Kelly-Hope, 2017, Loa loa vectors Chrysops spp.: perspectives on research, distribution, bionomics, and implications for elimination of lymphatic filariasis and onchocerciasis, Parasit. Vectors, 10, 172, 10.1186/s13071-017-2103-y Boussinesq, 2006, Loiasis, Ann. Trop. Med. Parasitol., 100, 715, 10.1179/136485906X112194 Arrey-Agbor, 2018, Case report: probable case of spontaneous encephalopathy due to Loiasis and dramatic reduction of Loa loa microfilariaemia with prolonged repeated courses of Albendazole, Am. J. Trop. Med. Hyg., 99, 112, 10.4269/ajtmh.17-0664 Centers for Disease Control and Prevention Casiraghi, 2004, Mapping the presence of Wolbachia pipientis on the phylogeny of filarial nematodes: evidence for symbiont loss during evolution, Int. J. Parasitol., 34, 191, 10.1016/j.ijpara.2003.10.004 Kivits, 1952, Four cases of fatal encephalopathy with invasion of the cerebrospinal fluid by microfilaria Loa, Ann. Soc. Belg. Med. Trop., 32, 235 Lukiana, 2006, A possible case of spontaneous Loa loa encephalopathy associated with a glomerulopathy, Filaria J., 5 Bhalla, 2013, Neurological manifestations of filarial infections, 114, 235, 10.1016/B978-0-444-53490-3.00018-2 Gobbi, 2018, Comparison of different drug regimens for the treatment of loiasis-A TropNet retrospective study, PLoS Negl. Trop. Dis., 12, 10.1371/journal.pntd.0006917 Blum, 2001, Encephalopathy following Loa loa treatment with albendazole, Acta Trop., 78, 63, 10.1016/S0001-706X(00)00159-5 Moliner, 2011, Loa loa meningoencephalitis secondary to treatment with mebendazol, Med. Clin., 136, 228, 10.1016/j.medcli.2010.02.003 Klion, 1993, Albendazole in human loiasis: results of a double-blind, placebo-controlled trial, J. Infect. Dis., 168, 202, 10.1093/infdis/168.1.202 Herrick, 2017, Posttreatment reactions after single-dose diethylcarbamazine or ivermectin in subjects with Loa loa infection, Clin. Infect. Dis., 64, 1017, 10.1093/cid/cix016 Wanji, 2017, Ivermectin treatment of Loa loa hyper-microfilaraemic baboons (Papio anubis): Assessment of microfilarial load reduction, haematological and biochemical parameters and histopathological changes following treatment, PLoS Negl. Trop. Dis., 11, 10.1371/journal.pntd.0005576 Scientific Working Group on Serious Adverse Events in Loa Loa endemic areas, 2003, Report of a Scientific Working Group on Serious Adverse Events following Mectizan(R) treatment of onchocerciasis in Loa loa endemic areas, Filaria J., 2 Massi, 2017, Post-ivermectin encephalopathy in Senegal: a case report, Pan Afr. Med. J., 27, 202 Taiwo, 2007, Loa loa meningoencephalitis in Southwestern Nigeria, West Afr. J. Med., 26, 156 Titulaer, 2013, Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study, Lancet. Neurol., 12, 157, 10.1016/S1474-4422(12)70310-1